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Abstract Most anti-cancer drug screening assays are
currently performed in two dimensions, on flat, rigid sur-
faces. However, there are increasing indications that three-
dimensional (3D) platforms provide a more realistic setting
to investigate accurate morphology, growth, and sensitivity
of tumor cells to chemical factors. Moreover, interstitial
flow plays a pivotal role in tumor growth. Here, we present
a microfluidic 3D platform to investigate behaviors of
tumor cells in flow conditions with anti-migratory com-
pounds. Our results show that interstitial flow and its
direction have significant impact on migration and growth
of hepatocellular carcinoma cell lines such as HepG2 and
HLE. In particular, HepG2/HLE cells tend to migrate
against interstitial flow, and their growth increases in
interstitial flow conditions regardless of the flow direction.
Furthermore, this migratory activity of HepG2 cells is
enhanced when they are co-cultured with human umbilical
vein endothelial cells. We also found that migration
activity of HepG2 cells attenuates under hypoxic condi-
tions. In addition, the effect of Artemisinin, an anti-
migratory compound, on HepG2 cells was quantitatively
analyzed. The microfluidic 3D platform described here is
useful to investigate more accurately the effect of anti-
migratory drugs on tumor cells and the critical influence of
interstitial flow than 2D culture models.
Keywords 3D cell migration  Microfluidics 
Anti-migratory drugs  Interstitial flow
2D Two dimensional
HCC Hepatocellular carcinoma
ART Artemisinin
PDMS Poly-dimethylsiloxane
VEGF Vascular endothelial growth factor
bFGF Basic fibroblast growth factor
HUVEC Human umbilical vein endothelial cell
PBS Phosphate-buffered saline
1 Introduction
Tumor cell migration is a critical factor in the context of
metastatic activity, and when a tumor has metastasized,
patients have less than 50 % chance to survive for more
than a year (Decaestecker et al. 2007). In the formation of
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metastases, tumor cells first migrate from the primary
tumor site to vessels as single cells or masses before
entering the circulation which transports them to distant
parts of the body. Primary liver cancers are usually treated
with pro-apoptotic anti-cancer drugs (Kinoshita et al. 2000;
Haga et al. 2003; Sekharam et al. 2003). However, by the
time metastases occur, tumor cells have already acquired a
resistance to these drugs. Therefore, an anti-migratory
strategy targeting metastatic tumor cells is highly desired
(Decaestecker et al. 2007).
Most anti-cancer drug screening assays have been per-
formed in two-dimensional (2D) culture models with cells
plated onto a flat surface, either treated plastic or, in some
cases, an extracellular matrix (ECM) analog. Nevertheless,
there is increasing evidence suggesting that three-dimen-
sional (3D) culture models in which the cells are immersed
in ECM are essential to investigate accurate cellular mor-
phology, growth, and reaction of tumor cells to chemical
factors (Gurski et al. 2010). One common alternative is the
use of in vivo models to investigate drug effects, but these
often suffer from the inability to make direct observations
and to regulate the local microenvironment; therefore, the
ability to understand all phenomena in vivo is greatly
compromised. In contrast, in vitro models have been
increasingly developed to allow for greater control of the
microenvironment and closer monitoring of the critical
phenomena. Therefore, 3D microfluidic systems have
emerged as powerful and controllable tools for manipu-
lating biochemical and biophysical microenvironments of
tumors. The most common 3D cell culture models are
composed of a collagen gel scaffold where cell aggregates
can grow naturally in a mechanical microenvironment that
mimics that of a tumor in vivo (Gurski et al. 2010). In order
to analyze behaviors of cells in the invasion and metastasis,
in vitro models must properly mimic the tumor microen-
vironments, and many parameters affecting tumor cell
behaviors need to be screened. In particular, interstitial
flow, biochemical compounds, ECM chemistry and
mechanics and local oxygen levels around cells are all key
factors.
The influence of these parameters was previously
documented using various 2D and 3D models (Decaes-
tecker et al. 2007). Particularly, interstitial flow, the con-
vective transport of fluid through tissue ECM, has been
demonstrated to affect the morphology and migration of
various cell types including endothelial cells and tumor
cells (Haessler et al. 2011). It is also known that inter-
stitial flow is related to the metastasis of tumors and the
guidance of tumor cell movement (Shieh and Swartz
2011). Therefore, recent studies have reproduced intersti-
tial flow in microfluidic systems to investigate its influ-
ence on tumor behaviors (Haessler et al. 2011; Polacheck
et al. 2011).
Previous in vitro models have been studying each of
tumor microenvironment parameters separately. However,
combining these parameters is important for controlling
tumor cell behaviors. Our microfluidic tumor cell migration
assay screened the effect of anti-migratory drugs in a 3D
platform, where interstitial flow, biochemical parameters
and ECM could be controlled precisely and simulta-
neously. In particular, we used interstitial flow to enhance
the migration of tumor cells against the flow and observe
more accurate tumor cell reaction to anti-migratory drugs.
Moreover, our system could be used in a hypoxic condition
and in the co-culture of tumor and other cells in combi-
nation with anti-migratory drugs.
Here, we present a microfluidic 3D platform to inves-
tigate behaviors of hepatocellular carcinoma (HCC), such
as HepG2 and HLE cells, in flow conditions with soluble
biochemical factors. This microfluidic device has been
used for hepatocyte-endothelial cell co-culture in our
previous study (Sudo et al. 2009). The microfluidic system
has many advantages over the conventional methods used
for tumor invasion studies such as culture inserts: abilities
to monitor 3D cell migration, to create co-culture with
defined cellular locations, and to culture tumor cells in
controlled biochemical and biophysical microenviron-
ments. The purpose of this study is to investigate HCC
cell behaviors under interstitial flow conditions in com-
bination with additional key factors such as anti-migratory
drug, endothelial cells and hypoxia. Our results demon-
strate that interstitial flow and its direction exerts a sig-
nificant influence on migration and growth of HCC cells.
HCC cells tend to migrate against interstitial flow, and
their growth is increased in the presence of interstitial
flow regardless of flow direction. Furthermore, the effect
of artemisinin (ART), an anti-migratory compound, on
HepG2 cells was quantitatively analyzed, and the influ-
ence of hypoxia was also investigated. We propose a new
approach using a 3D microfluidic device to study the
effect of anti-migratory drugs on tumor cells in a con-
trolled tumor microenvironment such as interstitial flow
conditions.
2 Materials and methods
2.1 Preparation of microfluidic devices
The shape and dimension of the gel region were designed to
produce capillary forces sufficient to confine and support the
injected gel solution. The width of the gel scaffold, 600 lm,
was selected to withstand the pressures and shear stresses
associated with interstitial flow across the gel and to promote
interactions between cells cultured in the two separate
microchannels (Fig. 1a). Channel width and height were
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selected to reduce shear stress on the cells during medium
replacement and to provide sufficient area for cell adhesion
to the sidewall of the gel scaffold (Sudo et al. 2009). Details
of the device fabrication process were described recently
(Shin et al. 2012). Briefly, the microfluidic device was made
of poly-dimethylsiloxane (PDMS; Silgard 184, Dow
Chemical, Midland, MI, USA) and was produced via soft
lithography with SU-8 patterned wafers. The PDMS device
with the surface patterning of microchannels was bonded to a
coverglass to form microchannels. After the microchannels
were coated with poly-D-lysine (Sigma-Aldrich, St. Louis,
MO, USA), prepolymerized type I collagen gel solution
(2 mg/ml, pH 7.4; BD Biosciences, San Jose, CA, USA) was
injected into the gel region through the injection ports and
placed in the humidified 5 % CO2 incubator at 37 C for
30 min to polymerize the solution. Microchannels were fil-
led with culture medium, and the microfluidic devices were
kept in the incubator until use.
2.2 Culture of HepG2, HLE and human umbilical vein
endothelial cells
Two human HCC cell lines, HepG2 and HLE, were pur-
chased from Health Science Research Resource Bank
Fig. 1 The microfluidic platform for investigating HepG2/HLE
migration. a Schematic diagram and dimension of the microfluidic
device made of PDMS. Two parallel microchannels are formed
between a micropatterned PDMS device and a coverglass. Collagen
gel is located between the microchannels with a mechanical support
of PDMS posts. b A picture of the microfluidic device cultured in a
flow condition. Reservoirs were connected to microchannels, and
interstitial flow across the collagen gel was generated by pressure
difference between two microchannels. c–f Phase-contrast images
taken on day 0, day 1, day 7 and day 14 of culture. Enlarged images
corresponding to the regions indicated by the rectangles in c–f were
shown in 1–4. HepG2 cells were seeded in the device on day 0, and
forward flow was applied to facilitate the 3D structure formation (an
arrow, c). Single HepG2 cells were stacked on the sidewall of the gel
or attached on the channel surface (1). On day 1, the flow is inversed
to remove debris (an arrow, d). Cells formed clusters but external
cells still showed single cell outlines (2). On day 2, cells were
cultured in three types of experimental condition, forward flow,
reverse flow, or static. Here, reverse flow is applied until day 14
(arrows, e, f). HepG2 cells formed tumor masses with relatively
smooth surface on days 7 and 14 (3, 4). Scale bars 1 cm (b) and
200 lm (c)
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(Osaka, Japan). HepG2 and HLE cells were derived from
well- and poorly differentiated HCC, respectively. The
cells were cultured in HCC media: DMEM (Invitrogen,
Carlsbad, CA, USA) supplemented with 10 % FBS, 20 ng/ml
vascular endothelial growth factor (VEGF), 20 ng/ml basic
fibroblast growth factor (bFGF) and antibiotics. Human
umbilical vein endothelial cells (HUVECs) were purchased
from Lonza (Walkerville, MD, USA) and cultured in HU-
VEC media: EGM-2 (Lonza) supplemented with 10 % FBS,
20 ng/ml VEGF and 20 ng/ml bFGF. HUVECs were
expanded in culture dishes within seven passages and seeded
into microfluidic devices. For co-culture experiments, HU-
VECs were added to HepG2/HLE culture on day 3. A 1:1
mixture of the HCC medium and HUVEC medium was used
for both co-culture and monoculture, and the medium was
replaced every day.
2.3 Protrusion formation assay and interstitial
flow generation
HepG2 or HLE cell suspensions (3 9 106 cells/ml, 20 ll
per device) were prepared and seeded into one of the two
microchannels (Fig. 1a). Details of the cell seeding process
were described recently (Shin et al. 2012). Briefly, the
device was tipped on its side and kept in the incubator for
30 min to allow cells to attach to the sidewall of the col-
lagen gel scaffold. Returning the device to horizontal, cells
were then cultured under constant flow condition in order
to promote cell adhesion to the gel. Interstitial flow was
generated as described in our previous study (Sudo et al.
2009). Briefly, medium reservoirs were inserted into the
channel outlets (Fig. 1b), and an interstitial flow across the
collagen gel was generated by a pressure difference of
5 mm H2O.
Forward flow, flow from HepG2 cells’ side to the other
side, was applied immediately after cell seeding. On the
next day (day 1), the interstitial flow was inversed (reverse
flow) in the manner described above, but with the pressure
difference reversed. These first 2 days were necessary to
generate a 3D structure of the tumor mass. From day 3, the
cells were cultured either in forward flow, reverse flow, or
under static conditions. Culture medium was replaced
every day. Phase-contrast images were taken every day to
observe HepG2/HLE protrusions and HepG2/HLE mass
expansion. The number of newly formed protrusions longer
than 100 lm and detaching from the tumor mass was
counted every day using phase-contrast images. The sum of
the protrusion numbers during culture periods was calcu-
lated and graphically shown for all experimental condi-
tions. For HepG2-HUVEC co-culture experiments,
HUVEC cell suspension (1 9 106 cells/ml, 20 ll per
device) was prepared and seeded into the other micro-
channel on day 2.
2.4 Anti-migratory compounds-ART
An anti-migratory compound, ART (Sigma-Aldrich) was
added to the culture media on both sides. HepG2 cells were
seeded in the microfluidic devices and cultured in the
medium supplemented with 200 lM ART. Culture med-
ium was replaced every day, and anti-migratory effects of
ART were monitored by phase-contrast microscopy. The
cells were also seeded in a culture dish and cultured in the
medium supplemented with ART to investigate the effect
of ART on cell–cell adhesion.
2.5 Immunofluorescence staining of cultured cells
Cells were fixed in 4 % paraformaldehyde for 30 min and
treated with 0.1 % Triton X-100 for 40 min. After rinsing
with phosphate-buffered saline (PBS), the cells were
incubated with Block Ace (Dainippon Pharma, Tokyo,
Japan) for 90 min. HCC cells were then incubated for 2 h
with mouse anti-pan cadherin antibody. After rinsing with
PBS, the cells were incubated for 2 h with Alexa Fluor 488
or 594-conjugated anti-mouse antibodies. Then after rins-
ing with PBS, the cells were incubated for 2 h with Alexa
Fluor 488 or 594-conjugated phalloidin. Nuclei were
counterstained with 40,6-diamidino-2-phenylindole
(Sigma-Aldrich) or propidium iodide (Invitrogen). The
z-axis series of fluorescence images was obtained using a
confocal laser-scanning microscope (LSM700; Carl Zeiss,
Hallbergmoos, Germany).
2.6 Hypoxia experiments
To investigate the effect of hypoxia on the behavior of
HepG2 cells, microfluidic devices were placed in an
incubator with the oxygen tension adjusted to 5 %. As a
control experiment, some microfluidic devices were cul-
tured in 21 % (air) oxygen. Culture medium was replaced
every day for both hypoxic and normoxic conditions.
2.7 Statistical analyses
Data are presented as mean ± SD. A Student’s t test was
used to test for differences, which were considered statis-
tically significant at error levels of ***p \ 0.001.
3 Results
3.1 HepG2/HLE cell protrusions and migration
To investigate HepG2/HLE cell behaviors in a controlled
microenvironment, HepG2 cells were cultured in the 3D
microfluidic platform (Fig. 1a, b). The cells attached on the
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sidewall of the collagen gel and cultured in forward flow to
form HepG2 cell aggregates (arrow, Fig. 1c). An enlarged
image showed that single HepG2 cells were stacked on the
sidewall of the collagen gel (enlarged image 1, Fig. 1c).
On day 1, the cells formed small aggregates on the sidewall
of the collagen gel (arrowheads, Fig. 1d). HepG2 clusters
with visible single cell outlines could also be observed
(enlarged image 2, Fig. 1d). The cells were then cultured in
reverse flow to remove debris within the aggregates (arrow,
Fig. 1d). In all experimental conditions, the cells were
cultured in the forward flow followed by reverse flow in the
first 2 days. From day 2, the cells were cultured either
under forward flow, reverse flow or static conditions. Here,
we showed the representative image of the cells cultured in
the reverse flow condition (Fig. 1e, f). We observed the
growth of HepG2 cell aggregates to form 3D tumor masses
during 14 days of culture (Fig. 1f). Enlarged images
showed the HepG2 cluster with relatively smooth surface
(enlarged images 3, 4, Fig. 1e, f).
We found that HepG2 cells extended protrusions from
the 3D tumor masses (arrowheads, Fig. 2a). Three-dimen-
sional projection images revealed that this HepG2 cell
migration occurred in 3D (arrowheads, Fig. 2b). Further-
more, in the development of HepG2 cell aggregates in the
microfluidic platform, tumor cell movements were divided
into several steps (Fig. 2c). First, HepG2 cells aggregated
and formed a 3D tumor mass, in which each cell showed
cuboidal/circular shape (Fig. 2c1). After day 5 or 6, the
next step of movements occurred where the cell membrane
spread into collagen gel (Fig. 2c2). Thereafter, nuclei
moved toward the membrane protrusion (Fig. 2c3). The
cells finally detached from the tumor mass to start migra-
tion into the collagen gel (Fig. 2c4). A few days later, the
cells changed their morphology to their original circular
shape but still continued to migrate (Fig. 2c5).
3.2 The effect of interstitial flow on HepG2/HLE cell
protrusions
To further investigate the HepG2 cell migration, cells were
cultured in three different conditions: forward flow, reverse
flow, and static conditions. When HepG2 cells were cultured
in the forward flow condition, few HepG2 cell protrusions
were observed during 14 days of culture (Fig. 3a). In the
Fig. 2 Five steps of liver cancer cell migration observed in the
microfluidic platform. a A phase-contrast image of a HepG2 cell
cluster with extending cytoplasmic protrusions (arrowheads). The
image was taken on day 9 cultured in the reverse flow condition.
HepG2 cells formed a 3D tumor mass before penetrating and
migrating into collagen gel. b A 3D projection image of confocal
fluorescent images showing HepG2 migration and tumor mass. The
cells were fixed on day 9 and stained for actin (green) and nuclei
(red). Note that the cells extended 3D protrusions into collagen gel
(arrowheads). c Corresponding fluorescent and phase-contrast images
of the representative five steps of HepG2 migration into collagen gel.
Cells were stained for actin (green) and nuclei (blue). Step 1: cells are
part of a tumor mass in a normal state. Step 2: a cell membrane starts
spreading into collagen gel. Step 3: a nucleus moves toward the
spreading membrane. Step 4: a cell detaches from the tumor mass and
migrates into collagen gel. Step 5: cell shape is back to its circular
shape. Arrowheads indicate protrusions of HepG2 cells. Scale bars
100 lm (a), 50 lm (b), and 50 lm (c)
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Fig. 3 Effect of interstitial flow
on HepG2/HLE protrusions.
Representative phase-contrast
images of HepG2 cells cultured
in forward flow (a), static (b), or
reverse flow (c) conditions.
Images were taken on day 14
and showed that reverse flow
increased the extent of HepG2
protrusions into collagen gel.
Scale bars 200 lm (a) and
100 lm (1). d Quantitative
analysis of the number of
HepG2 protrusions on day 14
cultured in forward flow, static
and reverse flow conditions
(***p \ 0.001). e Quantitative
analysis of the number of HLE
protrusions on day 14 in
forward flow, static and reverse
flow conditions (***p \ 0.001)
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static condition, some HepG2 cell protrusions were observed
(arrowheads, Fig. 3b). In contrast to these conditions, when
the cells were cultured in the reverse flow condition, HepG2
cells actively migrated into a collagen gel (arrowheads,
Fig. 3c). The quantitative analysis revealed that the number
of HepG2 cell protrusions in the reverse flow condition
increased 2.9-fold compared to the static condition, and
fourfold compared to the forward flow condition (Fig. 3d).
Fig. 4 Effect of interstitial flow on HepG2/HLE growth rate.
Corresponding phase-contrast images of HepG2 cells on days 1, 7
and 24, cultured in forward flow (a), static (b), and reverse flow
(c) conditions. Arrowheads indicate the edge of growing HepG2
clusters. d Quantitative analysis of HepG2 tumor mass growth rate
(lm2/day) cultured in forward flow (a), static (b) and reverse flow
(c) conditions. The area of the tumor mass in 2D projection image
was measured. The graph presents the average growth rate within
24 days of culture (***p \ 0.001). e Quantitative analysis was also
carried out for HLE (***p \ 0.001)
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Since HepG2 cells were well-differentiated HCC cells, we
also used HLE cells, poorly differentiated HCC cells, to
confirm this phenomenon. Quantitative analysis revealed
that HLE cells showed the same phenomenon of protrusion
to the interstitial flow applications (Fig. 3e). The number of
HLE cell protrusions in the reverse flow condition increased
1.8-fold compared to the static condition and 7.5-fold com-
pared to the forward flow condition.
3.3 The effect of interstitial flow on the growth
of HepG2/HLE masses
The same type of experiments using various interstitial flow
conditions allowed clear observation of the tumor mass
growth. When HepG2 cells were cultured in the forward
flow condition, the cells formed a tumor mass, which was
continuously expanding during 24 days of culture (Fig. 4a).
The tumor mass expanded not only into the microchannel,
but also toward the collagen gel (arrowheads, Fig. 4a). On
the other hand, when HepG2 cells were cultured in the static
condition, the tumor mass gradually expanded (Fig. 4b) but
did not expand into collagen gel (arrowheads, Fig. 4b).
When HepG2 cells were cultured in the reverse flow con-
dition, the tumor mass rapidly expanded, and the whole
width of the microchannel was occupied by the tumor mass
by day 24 (arrowheads, Fig. 4c). However, the tumor mass
did not expand into collagen gel even by day 24. Quanti-
tative analysis revealed that interstitial flow dramatically
promoted tumor growth (Fig. 4d). In both forward and
reverse flow conditions, the tumor mass attained a larger
size than in the static condition by day 24. More precisely,
HepG2 tumor mass growth rate in the reverse flow condi-
tion increased by 4.8 times compared to the static condition,
while that in the forward flow condition increased by 2.3
times compared to the static condition (Fig. 4d). This phe-
nomenon was also confirmed with HLE cells. HLE tumor
mass growth rate in the reverse flow condition increased by
3 times compared to the static condition, while that in the
forward flow condition increased by 1.7 times compared to
the static condition (Fig. 4e).
3.4 Application of an anti-migratory compound,
ART to the HepG2 3D culture model
To demonstrate one application of our microfluidic HCC
3D culture model, an anti-migratory compound, ART was
added to the culture medium and HepG2 cell behaviors
were analyzed. HepG2 cells were seeded and cultured with
ART under reverse flow or static conditions, where the
HepG2 cell protrusions were observed. Quantitative anal-
ysis revealed that the number of HepG2 protrusions in the
reverse flow condition decreased until day 10 (Fig. 5a). In
particular, ART treatment decreased the number of HepG2
protrusions by 40 % on day 7. However, this anti-migra-
tory effect gradually decreased during culture. The anti-
migratory effect of ART was progressively attenuated to
the point that there was no significant difference between
ART-treated cells and control cells after day 10. On the
other hand, the number of HepG2 protrusions in the static
condition also decreased by 40 % on day 7, but this
decrease sustained at least until day 17 (Fig. 5b).
3.5 ART improved HepG2 cell–cell adhesion
by renewing cadherin
HepG2 cells were also cultured in a 2D condition with
100 lM ART, and immunofluorescent staining was carried
Fig. 5 Quantitative analysis of the effect of ART on HepG2 cell
protrusions. a The number of HepG2 cell protrusions in the reverse
flow condition with/without ART. The graph presents the number of
protrusions over the culture period until day 17. The graph shows the
anti-migratory effect of ART on HepG2 cells and a decrease in
efficiency with time in culture (***p \ 0.001). b The number of
HepG2 cell protrusions in the static condition with/without ART. The
graph shows the anti-migratory effect of ART on HepG2 was retained
at least until day 17 (***p \ 0.001)
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out to investigate the effect of ART on HepG2 cell–cell
adhesion. The results revealed that HepG2 cells showed
low fluorescent intensity of cadherin at cell–cell borders in
a control experiment (Fig. 6a). However, when the cells
were cultured with ART, intense cadherin staining was
detected between HepG2 cells (Fig. 6b). Quantitative
analysis of the fluorescent intensity also confirmed this
phenomenon. Fluorescent intensity of cadherin with ART
treatment was more than threefold higher than control
(Fig. 6c).
3.6 Potential applications to HCC-HUVEC co-culture
and hypoxic condition
Finally, the HepG2/HLE cell culture model was extended to
co-culture with HUVEC or hypoxic conditions to further
demonstrate potential applications of the model. This cul-
ture model can readily be extended to co-culture since our
microfluidic device has two microchannels (Fig. 7a). In this
experiment, HUVECs were added to HepG2 culture on day
2 to start HepG2-HUVEC co-culture, and the cells were
cultured until day 14 (Fig. 7b–d). The cells were cultured in
the reverse flow or static conditions. In both conditions, co-
culture results showed a higher number of HepG2 cell
protrusions compared to monoculture (Fig. 7e). Protrusion
numbers increased in HepG2-HUVEC co-culture by 1.6
times both in the static and reverse flow conditions com-
pared to monoculture. This phenomenon was also con-
firmed in the experiment with HLE cells. The number of
HLE cell protrusions in HLE-HUVEC co-culture increased
by 2.6 times in the static condition, and by 2.7 times in the
reverse flow condition compared to monoculture (Fig. 7f).
To investigate the effect of a hypoxic environment on
HCC cell protrusions, we implemented two experiments
with HepG2 cells under normal oxygen condition (21 %
O2) and under hypoxic condition (5 % O2). The results
revealed that HepG2 cell protrusions in reverse flow con-
dition attenuated by the hypoxic condition (Fig. 7g). The
number of HepG2 cell protrusions in hypoxic condition
decreased by 70 % compared to normal oxygen condition.
Fig. 6 Effect of ART on
cadherin expression in HepG2
cells. Immunofluorescent
images for cadherin in HepG2
cells with (a) or without
(b) ART administration. Cells
were fixed on day 4, stained for
cadherin, and observed with a
940 objective lens. Images
show a higher cadherin
expression in HepG2 cells with
ART administration compared
to control experiment where the
cells were culture without ART
(control). Scale bar 20 lm (a).
c Quantitative analysis of the
cadherin expression intensity in
HepG2 cells with/without ART
administration (***p \ 0.001)
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4 Discussion
4.1 3D HCC cell migrations in a controlled
microenvironment
A 3D microfluidic platform was developed in this study for
investigating 3D migration of HCC cells, such as HepG2
and HLE cells, in flow conditions with the treatment of
anti-migratory drugs. HepG2/HLE cells first gathered to
form small aggregates and then expanded to form 3D
tumor masses. Thereafter, the cells migrated in 3D from the
tumor mass. The formation of the 3D tumor mass with
protrusions into collagen gel may mimic in vivo tumor
microenvironments compared to conventional 2D culture
models.
Our microfluidic platform, transparent and biocompati-
ble to maintain high cell viability, allowed us to clearly
monitor cellular morphogenesis by phase-contrast micros-
copy. We identified several steps in the process of the HCC
cell migration. During these steps, tumor cells attached to
Fig. 7 Potential extensions of
the microfluidic culture system
to co-culture and hypoxic
conditions. a Schematic
diagram of the HUVEC-HepG2
co-culture created in a
microfluidic platform. b–
d Corresponding phase-contrast
images of the co-culture system
in reverse flow conditions on
days 1, 2, and 8. The enlarged
image corresponding to the
rectangle 1 in d) was shown in
1. Arrowheads indicate HepG2
cell protrusions. e Quantitative
results of the number of HepG2
protrusions in static or reverse
flow conditions in HepG2
monoculture and HepG2-
HUVEC co-culture. Significant
difference appears in the reverse
flow condition, demonstrating
that HUVEC presence enhanced
HepG2 protrusions
(***p \ 0.001). f The number
of HLE protrusions was also
quantified for HLE monoculture
and HLE-HUVEC co-culture
(***p \ 0.001). g The number
of HepG2 protrusions in
normoxic (21 % O2) and
hypoxic (5 % O2) conditions.
HepG2 protrusions were
attenuated in hypoxic conditions
(***p \ 0.001)
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ECM via cell surface receptors, locally degraded the ECM,
protruded the cell membranes following the movement of
their nuclei and then detached from the tumor mass (Liotta
1986). Metastasis may take place by repeating these events.
4.2 Effect of interstitial flow on HCC cells
In the present study, interstitial flow application signifi-
cantly affected both migration and growth of HepG2/HLE
cells. In particular, both forward and reverse flow condi-
tions enhanced the growth of HepG2/HLE cells. Interstitial
flow has been previously observed to affect cellular
behavior and morphogenesis. In addition, interstitial fluid
pressure in most tumors is high, as supported by the sig-
nificantly positive correlation between interstitial fluid
pressure and the enlargement of tumor size (Gutmann et al.
1992; Raju et al. 2008).
An important finding was that HepG2/HLE cells tended
to migrate against the interstitial flow. Two mechanisms
have been proposed to explain why interstitial flow
increases tumor cell motility. One, which is consistent with
our observations, is an integrin-mediated mechanism
and dependent on interstitial flow direction and strength
(Polacheck et al. 2011). It has also been observed, at rela-
tively lower cell densities, that tumor cells migrate in the
direction of the flow. Haessler et al. (2011) reported that an
increase in interstitial flow was found in the microenvi-
ronment within a tumor mass and that the flow influenced
tumor cell migration. In particular, autologous chemotaxis,
a directed cell migration induced by interstitial flow, has
been identified as a potentially important mechanism; in
this case, cancer cells migrate in the direction of the flow
(Shieh and Swartz 2011; Fleury et al. 2006; Shields et al.
2007). In both cases, it is important to note that interstitial
flow dramatically increased the motility of tumor cells. In
the case of autologous chemotaxis, activation of the CCR7
receptor by the CCL21 ligand self-secreted by tumor cells
causes cell polarization and stimulates migration in the
direction of the flow. The direction of tumor cell migration
can thus be determined by the balance of these competing
mechanisms, suggesting that cell density, interstitial flow
rate, and CCR7 receptor availability are key factors for
controlling migratory activity of tumor cells (Polacheck
et al. 2011).
In the present experiments, we used both well- and
poorly differentiated HCC cells, HepG2 and HLE,
respectively. These cells responded to the interstitial flow
in a similar fashion, where the number of HepG2/HLE cell
protrusions increased in the reverse flow condition. How-
ever, the number of cell protrusions was much higher in
HLE cells than that in HepG2 cells. These results indicate
that the degree of differentiation of the cells may be
important to regulate the motility of tumor cells. In normal
liver, neighboring hepatocytes are bound with E-cadherin.
It is thought that poorly differentiated HLE cells express
less E-cadherin compared to well-differentiated HepG2
cells, which would contribute to the enhanced migratory
capacity of HLE cells. In addition, it was previously
demonstrated that pathophysiological behaviors of tumor
cells and their growth pattern were different depending on
the degree of cellular differentiation (Zheng et al. 2003;
Xin et al. 2001). The shape of the tumor cell protrusion,
which depends on the integrin-mediated cell adhesion to
ECM (Garcia et al. 1999), was also related to the degree of
cellular differentiation.
4.3 Application for anti-migratory drug screening
ART is a natural product isolated from the plant Artemisia
annua L., or sweet wormwood and has anti-migratory
effects on various tumor cell lines, including HCC cells
(Hou et al. 2008). We tested this compound in our 3D
HepG2 culture model to provide support for the use of this
model for drug screening. Since the device can be readily
visualized by phase-contrast microscopy, HepG2 cell
migrations were monitored and analyzed with or without
ART administration. As expected, ART treatment signifi-
cantly reduced the number of HepG2 cell protrusions. We
also confirmed that ART-treated HepG2 cells recovered
their cadherin localization at cell–cell borders. This
recovery of the cell–cell adhesion helps to explain the
decrease of the HepG2 cell migration because of the role of
E-cadherin in determining tumor progression (Jeanes et al.
2008). Tumor cells tend to progress through an epithelial–
mesenchymal transition marked by a loss of E-cadherin
expression, which results in an increase of metastatic
potential (Yang et al. 2005).
Our results demonstrate that the inhibitory effect of
ART on cell motility due to interstitial flow gradually
wanes in culture, while it is maintained under static con-
ditions. This suggests that interstitial flow may be critical
for the efficacy of ART on HepG2 cells. The previous
study suggested a correlation between response to the drug
treatment and interstitial pressures (Curti et al. 1993). An
important finding in the experiment using ART was that
HepG2 cells in a 3D microfluidic platform exhibited a
different response to ART compared to 2D studies. In 2D
culture, the inhibitory effect of ART on HepG2 cells
became stronger with time in culture (Weifeng et al. 2011).
The attenuation of ART effect observed in this study may
be due to the accelerated growth of HepG2 cells in inter-
stitial flow conditions, resulting in a higher consumption of
ART, a newly developed resistance to the drug, or a
physical response. In addition, both 3D structure and the
properties of the ECM exert important effects on drug
efficacy, influencing tissue architecture and cancer cell
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behavior and function compared to 2D models (Weigelt
et al. 2009). Therefore, 3D models such as our microfluidic
platform may be crucial to properly assess anti-cancer
drugs and their effect on tumor progression and metastasis.
4.4 Extensions of the model to more
pathophysiological conditions
Tumor cell behaviors are controlled by multiple factors in
the tumor microenvironment in vivo. It is therefore
important to consider interactions between tumor cells and
other components of the tumor microenvironment such as
the existence of endothelial cells. Co-culture of HepG2/
HLE cells and HUVECs led to the observation that HU-
VECs increase the number of HepG2/HLE cell protrusions
compared to monoculture. It has long been recognized that
tumor cells induce angiogenesis in vivo (Hanahan and
Weinberg 2011); however, it is not well understood if
endothelial cells induce migration of tumor cells. Our
results suggested that HUVECs secrete biochemical factors
that enhance HepG2/HLE cell migration. Further investi-
gations are needed to clarify the mechanisms of the
HUVEC influence on tumor cells.
Our model was also used to analyze tumor cell migra-
tion in a hypoxic condition. The level of oxygenation is
another key factor to be considered while investigating
tumor cell migration since hypoxia is well known to alter
tumor cell behavior (Chan and Giaccia 2007). Our results
demonstrated that the number of HepG2 cell protrusions is
reduced in hypoxia. A similar phenomenon was observed
in another experiment using different tumor cells, in which
hypoxia significantly decreased invasion of prostate cancer
cells (Ackerstaff et al. 2007).
In conclusion, our microfluidic device offers the potential
to analyze various factors that control tumor cell behavior,
for example, interstitial flow, anti-migratory compounds,
co-culture, and hypoxic conditions. This device is useful to
investigate more accurately the effect of anti-migratory
drugs on HCC cells and the critical influence of interstitial
flow than 2D culture models. Pharmaceutical studies could
therefore benefit from using a more physiological culture
model to screen and assess novel anti-cancer drugs. In
addition, in the future, one could use this strategy for per-
sonalized medicine in which numerous anti-cancer treat-
ments could be assessed on the patients’ own tumor cells to
choose the most efficient drug for their particular tumor.
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